Firebrick Pharma is just weeks away from finding out if it has cracked a cure for the common cold
Posted: 25 August 2023 How has your winter been? Have you managed to avoid illness like Covid-19, the flu or respiratory viruses associated with the common cold? Over at Firebrick Pharma (ASX:FRE), it’s spent the winter watching its Phase…
Prestigious Eureka Prize win recognises 4DMedical imaging innovation
Posted: 25 August 2023 4DMedical’s unique XV Technology™ has propelled a team of medical researchers to a 2023 Eureka Prize win, announced at a ceremony in Sydney last night. The Australian Museum Eureka Prizes are the country’s most…
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
Posted: 24 August 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the European Patent Office has granted Alterity a new composition…
MTPConnect Industry Fellowships Building Life Science Workforce Skills
Posted: 21 August 2023 MTPConnect is pleased to announce that a further two highly skilled Australian medical science researchers have been selected to work with leading South Korean pharmaceutical company Yuhan Corporation and pioneering RNA therapeutics company Moderna…
Pushing back against viruses with pandemic potential
Posted: 21 August 2023 Health Security Systems Australia (HSSA) is working with experts at the University of Melbourne at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), The University of Queensland’s National Biologics Facility, and industry…
MTPConnect Industry Fellowships Building Life Science Workforce Skills
Posted: 17 August 2023 MTPConnect is pleased to announce that a further two highly skilled Australian medical science researchers have been selected to work with leading South Korean pharmaceutical company Yuhan Corporation and pioneering RNA therapeutics company Moderna…
Moderna launches new R&D centre at Monash
Posted: 16 August 2023 US-based biotech company Moderna has opened its Regional Research Centre for Respiratory Medicines and Tropical Diseases and local headquarters in Melbourne, ahead of the expected opening of their mRNA factory next year. State industry minister…
Starpharma to receive A$6.5M from Mundipharma and rights to VivaGel® BV
Posted: 16 August 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it has negotiated a commercial settlement agreement with Mundipharma in relation to the VivaGel® BV product. Under the settlement: Starpharma will receive a US$4.25M (~A$6.54M) cash payment from…
Celebrating Manufacturing Excellence Across Victoria
Posted: 15 August 2023 Outstanding individuals and organisations in Victoria’s manufacturing sector have been celebrated for their achievements, with the 21st Victorian Manufacturing Hall of Fame Awards shining a spotlight on talent across the state. Minister for Manufacturing Sovereignty…
National Drug Discovery Centre announces new projects
Posted: 15 August 2023 Five research projects have been awarded generous Australian Government subsidies to fast-track their discoveries into new medicines using the National Drug Discovery Centre (NDDC). The NDDC’s National Steering Committee – an independent panel of drug…
Cracking the Golden Staph defence
Posted: 15 August 2023 New antibacterial medicines are urgently needed to respond to the problem of emerging drug-resistance. Causing more than 100,000 deaths a year globally, Methicillin-resistant Staphylococcus aureus (MRSA) – also known as Golden Staph – has been listed by…
Industry-first ESG guide for small biotechs
Posted: 15 August 2023 Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs. This provided the impetus for sector stronghold AusBiotech’s development…
